SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001521536-13-000295
Filing Date
2013-03-28
Accepted
2013-03-28 17:29:36
Documents
1
Period of Report
2013-03-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 q1101046_8k-biozone.htm 8-K 25331
  Complete submission text file 0001521536-13-000295.txt   26646
Mailing Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632
Business Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201-608-5101
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-146182 | Film No.: 13725192
SIC: 2834 Pharmaceutical Preparations